Efficacy of radioiodine therapy in the treatment of elevated serum thyroglobulin in patients with differentiated thyroid carcinoma and negative whole-body iodine scan

被引:16
|
作者
Saghari, Mohsen [1 ]
Gholamrezanezhad, Ali [1 ]
Mirpour, Sahar [1 ]
Eftekhari, Mohammad [1 ]
Takavar, Abbas [1 ]
Fard-Esfahani, Armaghan [1 ]
Fallahi, Babak [1 ]
Beiki, Davood [1 ]
机构
[1] Univ Tehran, Res Inst Nucl Med, Tehran 14114, Iran
关键词
differentiated thyroid carcinoma; thyroglobulin; whole-body scanning;
D O I
10.1097/00006231-200607000-00004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction In the management of patients with differentiated thyroid carcinoma, serum thyroglobulin levels are often well correlated with whole-body radioiodine scanning (WBS) results. However, occasionally, a mismatched result - increased thyroglobulin with negative WBS - is observed. Radioiodine therapy has been suggested as a therapeutic choice with controversial results. Method We studied 32 differentiated thyroid carcinoma patients with elevated thyroglobulin level and negative WBS who had been treated with high-dose radioiodine. With a mean follow-up of 25.6 months (all follow-ups > 11 months), thyroglobulin and thyroid-stimulating hormone levels, WBS, clinical, radiographic and pathological findings following treatment were recorded. Results The mean pre-therapy off-treatment thyroglobulin was 152 +/- 119.0 ng (.) ml(-1). Although there was a mild trend towards an increase in thyroglobulin in the first post-treatment year, the difference was not significant. At the end of the follow-ups, 22 patients (68.7%) were categorized as non-responders to radioiodine therapy (any change or elevation of thyroglobulin or radiological and pathological evidences of progression), four patients (12.5%) as partial responders (transient reduction but not a normalization of thyroglobulin) and six patients (18.7%) as responders (normalization of thyroglobulin with no evidence of remnant disease). In nine of 10 partial and complete responders, reduction or normalization of thyroglobulin had occurred in the first post-treatment year. Conclusion We recommend that in differentiated thyroid carcinoma patients with elevated thyroglobulin and negative WBS, at least one course of radioiodine therapy should be undertaken and if reduction or normalization of serum thyroglobulin is not achieved, repeated courses of radioiodine therapy are not logical and other therapeutic methods should be applied.
引用
收藏
页码:567 / 572
页数:6
相关论文
共 50 条
  • [41] Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin
    van Tol, KM
    Jager, PL
    de Vries, EGE
    Piers, DA
    Boezen, HM
    Sluiter, WJ
    Dullaart, RPF
    Links, TP
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 (06) : 589 - 596
  • [42] The Value of 99mTc-3PRGD2 SPECT/CT in Differentiated Thyroid Carcinoma with Negative 131I Whole-Body Scan and Elevated Thyroglobulin Levels
    Gao, Rui
    Li, Juan
    Wang, Yuanbo
    Liu, Yan
    Wang, Fan
    Li, Fang
    Yang, Aimin
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [43] Serum thyroglobulin concentrations and 131I whole-body scan results in patients with differentiated thyroid carcinoma after administration of recombinant human thyroid-stimulating hormone
    David, A
    Blotta, A
    Bondanelli, M
    Rossi, R
    Roti, E
    Braverman, LE
    Busutti, L
    Uberti, ECD
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (10) : 1470 - 1475
  • [44] Therapeutic Response Prediction Using Iodine Scan-Corrected Serum Thyroglobulin in Patients with Differentiated Thyroid Carcinoma
    Kwon, S.
    Chowdhury, M.
    Jeon, S.
    Kim, A.
    Kim, J.
    Song, H.
    Bom, H.
    Min, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S659 - S659
  • [45] Pitfalls of Iodine-131 whole-body scan mimicking metastases in differentiated thyroid carcinoma: A case series
    Shaik, Rishma
    Hemalatha, Dhamarcherla S.
    Rallapeta, Ramya Priya
    Sireesha, Polisetty
    Gavini, Surya Teja
    Kalawat, Tekchand
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2024, 39 (01): : 47 - 51
  • [46] Efficacy of Empirical 131I Radioiodine Therapy in Well-Differentiated Thyroid Carcinoma Patients With Thyroglobulin-Elevated Negative Iodine Scintigraphy Syndrome A Systematic Review and Meta-analysis
    Kim, Keunyoung
    Hong, Chae Moon
    Ha, Mihyang
    Choi, Miyoung
    Bang, Ji-In
    Park, Sohyun
    Seo, Youngduk
    Chong, Ari
    Oh, So Won
    Lee, Sang-Woo
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (08) : 741 - 747
  • [47] Octreotide scintigraphy in patients with differentiated thyroid carcinoma: Contribution for patients with negative radioiodine scan
    Baudin, E
    Schlumberger, M
    Lumbroso, J
    Travagli, JP
    Caillou, B
    Parmentier, C
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (07): : 2541 - 2544
  • [48] PROGNOSTIC VALUE OF UNDETECTABLE LEVELS OF SERUM THYROGLOBULIN OBTAINED IN DESUPPRESSION DURING RADIOIODINE TREATMENT OF DIFFERENTIATED THYROID-CARCINOMAS - COMPARISON WITH WHOLE-BODY SCINTIGRAPHY
    LEFORT, G
    DUBOURG, H
    BRENDEL, AJ
    LATAPIE, MJ
    DUCASSOU, D
    LATAPIE, JL
    ANNALES D ENDOCRINOLOGIE, 1987, 48 (03) : 195 - 195
  • [49] 99mTc-HYNIC-TOC scintigraphy in patients with differentiated thyroid carcinoma and negative iodine whole body scan.
    Czepczynski, R.
    Matysiak-Grzes, M.
    Gryczynska, M.
    Baczyk, M.
    Sowinski, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S245 - S245
  • [50] Clinical comparison of whole-body radioiodine scan and serum thyroglobulin after stimulation with recombinant human thyrotropin
    Haugen, BR
    Ridgway, EC
    McLaughlin, BA
    McDermott, MT
    THYROID, 2002, 12 (01) : 37 - 43